| Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids KK Dijkstra, CM Cattaneo, F Weeber, M Chalabi, J van de Haar, ... Cell 174 (6), 1586-1598. e12, 2018 | 949 | 2018 |
| Tumor organoid–T-cell coculture systems CM Cattaneo, KK Dijkstra, LF Fanchi, S Kelderman, S Kaing, N van Rooij, ... Nature protocols 15 (1), 15-39, 2020 | 300 | 2020 |
| Werner helicase is a synthetic-lethal vulnerability in mismatch repair–deficient colorectal cancer refractory to targeted therapies, chemotherapy, and immunotherapy G Picco, CM Cattaneo, EJ van Vliet, G Crisafulli, G Rospo, S Consonni, ... Cancer discovery 11 (8), 1923-1937, 2021 | 80 | 2021 |
| Base editing screens map mutations affecting interferon-γ signaling in cancer MA Coelho, S Cooper, ME Strauss, E Karakoc, S Bhosle, E Goncalves, ... Cancer Cell 41 (2), 288-303. e6, 2023 | 41 | 2023 |
| Identification of patient-specific CD4+ and CD8+ T cell neoantigens through HLA-unbiased genetic screens CM Cattaneo, T Battaglia, J Urbanus, Z Moravec, R Voogd, R de Groot, ... Nature biotechnology 41 (6), 783-787, 2023 | 30 | 2023 |
| A Novel Mecp2Y120D Knock-in Model Displays Similar Behavioral Traits But Distinct Molecular Features Compared to the Mecp2-Null Mouse Implying Precision … A Gandaglia, E Brivio, S Carli, M Palmieri, F Bedogni, G Stefanelli, ... Molecular neurobiology 56, 4838-4854, 2019 | 29 | 2019 |
| Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicity C Vennin, CM Cattaneo, L Bosch, S Vegna, X Ma, HGJ Damstra, ... Cancer cell 41 (6), 1170-1185. e12, 2023 | 27 | 2023 |
| Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance V Amodio, S Lamba, R Chilà, CM Cattaneo, B Mussolin, G Corti, G Rospo, ... Cancer Cell 41 (1), 196-209. e5, 2023 | 23 | 2023 |
| Tumor organoids as a research tool: how to exploit them TH Booij, CM Cattaneo, CK Hirt Cells 11 (21), 3440, 2022 | 8 | 2022 |
| Base editing screens define the genetic landscape of cancer drug resistance mechanisms MA Coelho, ME Strauss, A Watterson, S Cooper, S Bhosle, G Illuzzi, ... Nature Genetics, 1-14, 2024 | 1 | 2024 |
| Identification of personalized cancer neoantigens with HANSolo CM Cattaneo Nature Reviews Cancer 23 (12), 800-800, 2023 | 1 | 2023 |
| Urbanus CM Cattaneo, T Battaglia Mora ec, Z., Voogd, R., Groot, R. de,… Scheper, W, 783-787, 2023 | | 2023 |
| 54P Identification of patient-specific T-cell neoantigens through HLA-agnostic genetic screens W Scheper, C Cattaneo, J Urbanus, T Battaglia, J Haanen, EE Voest, ... Annals of Oncology 32, S1362, 2021 | | 2021 |
| On the road to personalized immunotherapy: an unexpected journey CM Cattaneo Utrecht University, 2021 | | 2021 |
| Breaking Insights KK Dijkstra, CM Cattaneo, F Weeber, M Chalabi, J van de Haar, ... | | |
